LOS ANGELES--(BUSINESS WIRE)-- Global Coalition for Adaptive Research (GCAR) today announced an update on the progress of GBM AGILE (Glioblastoma Adaptive Global Innovative Learning Environment - ...
AstraZeneca's AZD1390 Now Enrolling in GBM AGILE, a Registrational-Intent Phase 2/3 Adaptive Platform Trial for Patients with Glioblastoma AZD1390 Arm Will Recruit Patients with Newly Diagnosed ...
If you do a little research about Scrum, you might find diametrically opposed opinions—either it’s the best thing that can happen to an IT business, or it’s a waste of time. Many startup founders are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results